Wells Fargo’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-389,952
Closed -$1.23M 7081
2020
Q3
$1.23M Buy
389,952
+62,173
+19% +$196K ﹤0.01% 3623
2020
Q2
$953K Buy
327,779
+39,287
+14% +$114K ﹤0.01% 3755
2020
Q1
$814K Sell
288,492
-168,179
-37% -$475K ﹤0.01% 3581
2019
Q4
$1.48M Sell
456,671
-236,234
-34% -$766K ﹤0.01% 3537
2019
Q3
$1.5M Sell
692,905
-29,691
-4% -$64.1K ﹤0.01% 3511
2019
Q2
$2.27M Buy
722,596
+382,397
+112% +$1.2M ﹤0.01% 3209
2019
Q1
$1.27M Sell
340,199
-5,387
-2% -$20K ﹤0.01% 3675
2018
Q4
$1M Buy
345,586
+1,187
+0.3% +$3.44K ﹤0.01% 3770
2018
Q3
$905K Buy
344,399
+16,140
+5% +$42.4K ﹤0.01% 3966
2018
Q2
$768K Sell
328,259
-21,293
-6% -$49.8K ﹤0.01% 4099
2018
Q1
$1.03M Sell
349,552
-43,575
-11% -$128K ﹤0.01% 3836
2017
Q4
$1.08M Buy
393,127
+47,070
+14% +$129K ﹤0.01% 3814
2017
Q3
$1.17M Buy
346,057
+10,239
+3% +$34.7K ﹤0.01% 3679
2017
Q2
$829K Sell
335,818
-270,840
-45% -$669K ﹤0.01% 3797
2017
Q1
$1.38M Sell
606,658
-42,760
-7% -$97.1K ﹤0.01% 3452
2016
Q4
$1.38M Buy
649,418
+458,825
+241% +$972K ﹤0.01% 3409
2016
Q3
$639K Sell
190,593
-255,492
-57% -$857K ﹤0.01% 3718
2016
Q2
$1.4M Sell
446,085
-250,555
-36% -$787K ﹤0.01% 3190
2016
Q1
$2.32M Sell
696,640
-74,106
-10% -$247K ﹤0.01% 2795
2015
Q4
$2.73M Sell
770,746
-1,209,648
-61% -$4.28M ﹤0.01% 2724
2015
Q3
$9.96M Buy
1,980,394
+55,369
+3% +$278K ﹤0.01% 1793
2015
Q2
$12.4M Sell
1,925,025
-523,298
-21% -$3.37M ﹤0.01% 1732
2015
Q1
$17.2M Sell
2,448,323
-767,336
-24% -$5.4M 0.01% 1440
2014
Q4
$24.8M Sell
3,215,659
-832,793
-21% -$6.42M 0.01% 1152
2014
Q3
$30.2M Sell
4,048,452
-50,460
-1% -$377K 0.01% 1005
2014
Q2
$39.7M Buy
4,098,912
+1,413,224
+53% +$13.7M 0.02% 891
2014
Q1
$22.3M Buy
2,685,688
+2,048,581
+322% +$17M 0.01% 1191
2013
Q4
$5.38M Buy
637,107
+98,433
+18% +$831K ﹤0.01% 2206
2013
Q3
$4.29M Sell
538,674
-47,498
-8% -$379K ﹤0.01% 2302
2013
Q2
$4.52M Buy
+586,172
New +$4.52M ﹤0.01% 2201